{"version":"1.0","provider_name":"CUTIS LAXA INTERNATIONALE","provider_url":"https:\/\/www.cutislaxa.org\/fr\/","title":"Astrazeneca a d\u00e9cern\u00e9 son \u00ab\u00a0Prix Scientifique\u00a02024 \u00bb au Pr Bert Callewaert - CUTIS LAXA INTERNATIONALE","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"mMJ4BFrtJp\"><a href=\"https:\/\/www.cutislaxa.org\/fr\/17048\/\">Astrazeneca a d\u00e9cern\u00e9 son \u00ab\u00a0Prix Scientifique\u00a02024 \u00bb au Pr Bert Callewaert<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.cutislaxa.org\/fr\/17048\/embed\/#?secret=mMJ4BFrtJp\" width=\"600\" height=\"338\" title=\"\u00ab\u00a0Astrazeneca a d\u00e9cern\u00e9 son \u00ab\u00a0Prix Scientifique\u00a02024 \u00bb au Pr Bert Callewaert\u00a0\u00bb &#8212; CUTIS LAXA INTERNATIONALE\" data-secret=\"mMJ4BFrtJp\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/* ]]> *\/\n<\/script>\n","thumbnail_url":"https:\/\/www.cutislaxa.org\/wp-content\/uploads\/2018\/01\/logo-cmgg-Pr-Bert-CALLEWAERT.jpg","thumbnail_width":300,"thumbnail_height":208,"description":"Le 12 D\u00e9cembre 2024, Astrazeneca a d\u00e9cern\u00e9 son \u00ab\u00a0Prix Scientifique\u00a02024 \u00bb au Pr Bert Callewaert . Nous sommes tr\u00e8s heureux et fiers que le Pr Callewaert soit un des rares experts mondiaux de la Cutis Laxa. Il est recompens\u00e9 pour ses recherches sur les maladies cong\u00e9nitales rares des fibres \u00e9lastiques, incluant la Cutis Laxa et [&hellip;]"}